secwatch.observer — SEC 8-K summary
======================================

Issuer:     ArriVent BioPharma, Inc. (AVBP)
CIK:        0001868279
Form:       8-K
Filed at:   2024-01-30T23:59:59+00:00
Accession:  0001104659-24-008228
Event type: other_material
Sentiment:  positive
Materiality: 0.70
Item codes: 5.03, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

ArriVent BioPharma completes IPO of 9.7M shares at $18, raising ~$175M
----------------------------------------------------------------------

- IPO of 9,722,222 shares of common stock at $18.00 per share closed January 30, 2024.
- Gross proceeds to the company were approximately $175.0 million before expenses.
- Amended and restated certificate of incorporation and bylaws filed and effective upon IPO closing.
- Common stock trades on Nasdaq under ticker AVBP.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1868279/000110465924008228/0001104659-24-008228-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1868279/000110465924008228/tm2321853d25_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-24-008228

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer